These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
110 related items for PubMed ID: 17489974
1. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients. Heller M, Shin HT, Orlow SJ, Schaffer JV. Br J Dermatol; 2007 Jul; 157(1):127-32. PubMed ID: 17489974 [Abstract] [Full Text] [Related]
2. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients]. Ballester I, Silvestre JF, Pérez-Crespo M, Lucas A. Actas Dermosifiliogr; 2009 Dec; 100(10):883-7. PubMed ID: 20038365 [Abstract] [Full Text] [Related]
3. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis. Murray ML, Cohen JB. Clin Exp Dermatol; 2007 Jan; 32(1):23-7. PubMed ID: 17059445 [Abstract] [Full Text] [Related]
4. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis. Dias-Polak D, Bergman R, Avitan-Hersh E. J Dermatolog Treat; 2019 Feb; 30(1):49-51. PubMed ID: 29683760 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil is effective in the treatment of atopic dermatitis. Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM. Arch Dermatol; 2001 Jul; 137(7):870-3. PubMed ID: 11453805 [Abstract] [Full Text] [Related]
6. Treatment of atopic eczema with oral mycophenolate mofetil. Neuber K, Schwartz I, Itschert G, Dieck AT. Br J Dermatol; 2000 Aug; 143(2):385-91. PubMed ID: 10951150 [Abstract] [Full Text] [Related]
7. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]. Greiner K, Varikkara M, Santiago C, Forrester JV. Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257 [Abstract] [Full Text] [Related]
8. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. Budde K, Glander P, Krämer BK, Fischer W, Hoffmann U, Bauer S, Grohmann J, Neumayer HH, Arns W. Transplantation; 2007 Feb 27; 83(4):417-24. PubMed ID: 17318074 [Abstract] [Full Text] [Related]
9. Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres. Garritsen FM, Roekevisch E, van der Schaft J, Deinum J, Spuls PI, de Bruin-Weller MS. J Eur Acad Dermatol Venereol; 2015 Oct 27; 29(10):1905-12. PubMed ID: 25752497 [Abstract] [Full Text] [Related]
10. Mycophenolate mofetil in the treatment of uveitis in children. Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M. Br J Ophthalmol; 2007 Feb 27; 91(2):180-4. PubMed ID: 16825275 [Abstract] [Full Text] [Related]
11. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review. Prussick L, Plotnikova N, Gottlieb A. J Drugs Dermatol; 2016 Jun 01; 15(6):715-8. PubMed ID: 27272078 [Abstract] [Full Text] [Related]
12. A pilot study of tacrolimus and mycophenolate mofetil graft-versus-host disease prophylaxis in childhood and adolescent allogeneic stem cell transplant recipients. Osunkwo I, Bessmertny O, Harrison L, Cheung YK, Van de Ven C, del Toro G, Garvin J, George D, Bradley MB, Wolownik K, Wischhover C, Levy J, Skerrett D, Cairo MS. Biol Blood Marrow Transplant; 2004 Apr 01; 10(4):246-58. PubMed ID: 15077223 [Abstract] [Full Text] [Related]
13. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report]. Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA. Przegl Lek; 2006 Apr 01; 63 Suppl 3():44-8. PubMed ID: 16898486 [Abstract] [Full Text] [Related]
14. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Filler G, Foster J, Berard R, Mai I, Lepage N. Transplant Proc; 2004 Jun 01; 36(5):1327-31. PubMed ID: 15251324 [Abstract] [Full Text] [Related]
15. Mycophenolate mofetil for the treatment of scleritis. Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR. Ophthalmology; 2003 Sep 01; 110(9):1750-5. PubMed ID: 13129873 [Abstract] [Full Text] [Related]
16. Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus. Chatur N, Ramji A, Bain VG, Ma MM, Marotta PJ, Ghent CN, Lilly LB, Heathcote EJ, Deschenes M, Lee SS, Steinbrecher UP, Yoshida EM. Liver Int; 2005 Aug 01; 25(4):723-7. PubMed ID: 15998421 [Abstract] [Full Text] [Related]
17. First experience with enteric-coated mycophenolate sodium (Myfortic) in severe recalcitrant adult atopic dermatitis: an open label study. van Velsen SG, Haeck IM, Bruijnzeel-Koomen CA, de Bruin-Weller MS. Br J Dermatol; 2009 Mar 01; 160(3):687-91. PubMed ID: 19120337 [Abstract] [Full Text] [Related]
18. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients. Wee JS, Shirlaw PJ, Challacombe SJ, Setterfield JF. Br J Dermatol; 2012 Jul 01; 167(1):36-43. PubMed ID: 22309851 [Abstract] [Full Text] [Related]
19. Liver enzyme abnormalities in patients with atopic dermatitis treated with mycophenolate mofetil. Hantash B, Fiorentino D. Arch Dermatol; 2006 Jan 01; 142(1):109-10. PubMed ID: 16415398 [No Abstract] [Full Text] [Related]
20. Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years. Jungraithmayr T, Staskewitz A, Kirste G, Böswald M, Bulla M, Burghard R, Dippell J, Greiner C, Helmchen U, Klare B, Klaus G, Leichter HE, Mihatsch MJ, Michalk DV, Misselwitz J, Plank C, Querfeld U, Weber LT, Wiesel M, Tönshoff B, Zimmerhackl LB, German Pediatric Renal Transplantation Study Group. Transplantation; 2003 Feb 27; 75(4):454-61. PubMed ID: 12605109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]